Bioventus Inc.
BVS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $42 | $37 | $30 | $44 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $127 | $123 | $136 | $125 |
| Inventory | $92 | $91 | $85 | $62 |
| Other Curr. Assets | $14 | $17 | $21 | $33 |
| Total Curr. Assets | $276 | $268 | $273 | $263 |
| Property Plant & Equip (Net) | $34 | $50 | $44 | $40 |
| Goodwill | $7 | $7 | $7 | $148 |
| Intangibles | $405 | $482 | $640 | $695 |
| Long-Term Investments | $0 | $0 | $3 | $29 |
| Tax Assets | $5 | $0 | $0 | $0 |
| Other NC Assets | $2 | $3 | $406 | $50 |
| Total NC Assets | $452 | $543 | $1,100 | $963 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $728 | $811 | $1,373 | $1,226 |
| Liabilities | – | – | – | – |
| Payables | $24 | $23 | $37 | $17 |
| Short-Term Debt | $27 | $28 | $33 | $18 |
| Tax Payable | $4 | $5 | $3 | $8 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $156 | $120 | $232 | $138 |
| Total Curr. Liab. | $210 | $175 | $304 | $181 |
| LT Debt | $308 | $367 | $385 | $340 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $1 | $1 | $2 | $134 |
| Other NC Liab. | $23 | $46 | $269 | $38 |
| Total NC Liab. | $332 | $414 | $656 | $511 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $542 | $590 | $960 | $692 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$355 | -$322 | -$165 | -$7 |
| AOCI | -$3 | $1 | -$0 | $0 |
| Other Equity | $506 | $494 | $491 | $465 |
| Total Equity | $148 | $174 | $325 | $459 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $38 | $48 | $87 | $75 |
| Total Liab. & Tot. Equity | $728 | $811 | $1,373 | $1,226 |
| Net Debt | $294 | $358 | $388 | $314 |